Kait Pharma Distribution Private Limited
Founded in 2023 and headquartered in Kerala, India.
2023 | Ernakulam, Kerala (India) | Active
Kait Pharma Distribution Profile
Key Indicators
- Authorised Capital ₹ 50.00 K
- Paid Up Capital ₹ 50.00 K
- Company Age 2 Year, 4 Days
- Open Charges ₹ 1.01 M
About Kait Pharma Distribution
Kait Pharma Distribution Private Limited (KPDPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 February 2023 (Two years 4 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 50.00 K and a paid-up capital of Rs 50.00 K .
The company currently has active open charges totaling ₹1.01 M.
Soloman Thomas, Sheba Thomas, and Moushumy Antony serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U47721KL2023PTC080237
- Company No.
080237
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Who are the key members and board of directors at Kait Pharma Distribution?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Soloman Thomas  | Managing Director | 12-Mar-2024 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sheba Thomas | Director | 23-Feb-2023 | Current |
| Moushumy Antony | Director | 23-Feb-2023 | Current |
Financial Performance of Kait Pharma Distribution.
Enhance accessibility to Kait Pharma Distribution's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kait Pharma Distribution?
Unlock access to Kait Pharma Distribution's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kait Mart International Private Limited
Soloman Thomas, Sheba Thomas and 1 more are mutual person
Charges (Loans)
Open Charges
₹1,010,000.00
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Oct 2023 | State Bank Of India | ₹1.01 M | Open |
How Many Employees Work at Kait Pharma Distribution?
Unlock and access historical data on people associated with Kait Pharma Distribution, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kait Pharma Distribution, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kait Pharma Distribution's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.